Close
Nordic 9Nordic 9

Boxer Capital (investor - Private Equity)

United States boxercap.com
See something wrong or missing? Let us know
Offices:San Diego

Boxer Capital, LLC was founded by the life sciences team at Tavistock Group in 2005 as a private biotechnology investment fund that invents and invests in new therapeutics across multiple indications.

Average round investment:70.13M USD
Average number per year:1.0
Distribution: 2020 (1)
Portfolio companies: United Kingdom Achilles Therapeutics
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Boxer Capital

Name Criteria
United Kingdom Syncona
70%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Morningside Ventures
67%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adjuvant Capital
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bristol-Myers Squibb
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cormorant Asset Management
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States EcoR1 Capital
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Famille C Invest
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Foresite Capital
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Galaxy Digital
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Hitachi Ventures
66%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top